Published in Harefuah on May 15, 1995
Tumor spectrum analysis in p53-mutant mice. Curr Biol (1994) 16.60
Results of conservative management of clinically localized prostate cancer. N Engl J Med (1994) 5.04
Frequent inactivation of PTEN/MMAC1 in primary prostate cancer. Cancer Res (1997) 4.73
Polarity-specific activities of retinoic acid receptors determined by a co-repressor. Nature (1995) 3.90
p300 is a component of an estrogen receptor coactivator complex. Proc Natl Acad Sci U S A (1996) 2.58
Rapid p53 sequence analysis in primary lung cancer using an oligonucleotide probe array. Proc Natl Acad Sci U S A (1999) 2.08
Endotoxin-induced shedding of viable uroepithelial cells is an antimicrobial defense mechanism. Infect Immun (1988) 1.42
Is there a role for low doses of mitotane (o,p'-DDD) as adjuvant therapy in adrenocortical carcinoma? J Clin Endocrinol Metab (1998) 1.42
Malignant peripheral primitive neuroectodermal tumor (PNET) of the kidney. Med Pediatr Oncol (1994) 1.41
Quantitative SPECT of technetium-99m-DMSA uptake in the kidneys of normal children and in kidneys with vesicoureteral reflux: detection of unilateral kidney disease. J Nucl Med (1994) 1.40
A remote controlled intraurethral insert for artificial voiding: a new concept for treating women with voiding dysfunction. J Urol (1999) 1.39
Testicular seminoma: clinical significance of nuclear deoxyribonucleic acid ploidy pattern as studied by flow cytometry. J Urol (1995) 1.39
Flow cytometric DNA analysis of classic and steroid-induced Kaposi's sarcoma. Br J Dermatol (1995) 1.37
Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: randomized, placebo-controlled, double-blind study. National Institute of Allergy and Infectious Diseases Mycoses Study Group. Clin Infect Dis (1999) 1.32
Noninvasive detection of bladder cancer with the BTA stat test. J Urol (1999) 1.26
Sutureless nephron-sparing surgery: use of albumin glutaraldehyde tissue adhesive (BioGlue). Urology (2006) 1.23
Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer. Urology (2004) 1.22
Genetic alterations in urinary bladder carcinosarcoma: evidence of a common clonal origin. Eur Urol (2000) 1.18
Preliminary European results of local microwave hyperthermia and chemotherapy treatment in intermediate or high risk superficial transitional cell carcinoma of the bladder. Eur Urol (2004) 1.13
Incisionless per vaginal bone anchor cystourethropexy for the treatment of female stress incontinence: experience with the first 50 patients. J Urol (1997) 1.07
Effect of percutaneous nephrolithotripsy on renal function: assessment with quantitative SPECT of (99m)Tc-DMSA renal scintigraphy. J Endourol (2006) 1.01
Clinical significance of tumor angiogenesis in patients with localized renal cell carcinoma. Urology (1998) 1.00
Bone anchored sling for the treatment of post-prostatectomy incontinence. J Urol (2001) 1.00
Long-term followup of patients less than 30 years old with transitional cell carcinoma of bladder. J Urol (1988) 0.99
Somatic mutations of the PTEN tumor suppressor gene in sporadic follicular thyroid tumors. Genes Chromosomes Cancer (1998) 0.97
An operation for incisional lumbar hernia. Eur Urol (1991) 0.97
Does long-term itraconazole prophylaxis result in in vitro azole resistance in mucosal Candida albicans isolates from persons with advanced human immunodeficiency virus infection? The National Institute of Allergy and Infectious Diseases Mycoses study group. Antimicrob Agents Chemother (2000) 0.96
Facilitation of glutamate receptors reverses an age-associated memory impairment in rats. Synapse (1996) 0.92
The use of an ultrasonic assisted lipectomy device for the treatment of obstructive pelvic lipomatosis. Urology (1996) 0.90
Intravesical hyperthermia and mitomycin-C for carcinoma in situ of the urinary bladder: experience of the European Synergo working party. World J Urol (2009) 0.89
Quantitative SPECT of DMSA uptake by the kidneys: assessment of reproducibility. Kidney Int (1997) 0.88
Thermo-chemotherapy for intermediate or high-risk recurrent superficial bladder cancer patients. Ann Oncol (2005) 0.88
Kidney function after radical nephrectomy: assessment by quantitative SPECT of 99mTc-DMSA uptake by the kidneys. J Nucl Med (2000) 0.88
Sublingual buprenorphine compared to morphine delivered by a patient-controlled analgesia system as postoperative analgesia after prostatectomy. Urol Int (1996) 0.87
Multimodality imaging of direct ureteric involvement in non-Hodgkin's lymphoma using PET/CT, CT urography and antegrade CT pyelography. Br J Radiol (2007) 0.86
Stage B prostate adenocarcinoma. Flow cytometric nuclear DNA ploidy analysis. Arch Surg (1990) 0.85
Decompensated ureteropelvic junction obstruction in renal allograft. J Urol (1988) 0.85
Hypertrichosis in Becker's nevus: effective low-fluence laser hair removal. Lasers Med Sci (2013) 0.84
DNA methylation profiles delineate epigenetic heterogeneity in seminoma and non-seminoma. Br J Cancer (2011) 0.84
Reconsidering the necessity of ipsilateral adrenalectomy during radical nephrectomy for renal cell carcinoma. Urology (1995) 0.83
Numb chin syndrome as the presenting symptom of metastatic prostate carcinoma. Urology (2000) 0.83
[Transthoracic approach for removing adrenal masses]. Harefuah (1996) 0.83
Urinary infections following transurethral resection of bladder tumors--rate and source. J Urol (1983) 0.82
Microsatellite analysis and telomerase activity in archived tissue and urine samples of bladder cancer patients. Int J Cancer (1997) 0.82
ETView tracheoscopic ventilation tube for surveillance after tube position in patients undergoing percutaneous nephrolithotomy. Br J Anaesth (2010) 0.82
Anuria and acute renal failure caused by multiple bladder calculi. Int Urol Nephrol (1996) 0.82
The role of vimentin expression in predicting the long-term outcome of patients with localized renal cell carcinoma. Br J Urol (1997) 0.81
The malignant potential of postchemotherapy residual mature teratoma for disseminated nonseminomatous testicular tumors. Eur Urol (1994) 0.81
Intravesical irrigation with distilled water during and immediately after transurethral resection and later for superficial bladder cancer. Eur Urol (1987) 0.81
Primary chondrosarcoma of the kidney. J Urol (1985) 0.81
A comparison between histological grade and nuclear morphometry for predicting the clinical outcome of localized renal cell carcinoma. Br J Urol (1996) 0.81
The relationship between clinical stage, natural killer activity and related immunological parameters in adenocarcinoma of the prostate. Cancer Immunol Immunother (1989) 0.80
Renal function after tumor enucleation: assessment by quantitative SPECT of 99mTc-dimercaptosuccinic acid uptake by the kidneys. J Nucl Med (1999) 0.80
Premature ovarian failure--the prognostic application of autoimmunity on conception after ovulation induction. Fertil Steril (1993) 0.80
Radiation-induced tumors in irradiated stage I testicular seminoma: results of a 25-year follow-up (1968-1993). J Surg Oncol (1998) 0.80
Prophylactic antimicrobial treatment in transurethral prostatectomy. How long should it be instituted? Urology (1983) 0.79
Cancer of the prostate: is there a need for aggressive treatment? Urol Int (1987) 0.79
How accurate is helical CT volumetric assessment in renal tumors? Eur Radiol (2001) 0.79
Effect of distilled water and bacillus Calmette-Guérin on exfoliated bladder tumor cells. Eur Urol (1991) 0.79
Spontaneous rupture of renal angiomyolipoma. Report of three cases. Eur Urol (1984) 0.79
Detection of prostate cancer by radio-frequency near-field spectroscopy in radical prostatectomy ex vivo specimens. Prostate Cancer Prostatic Dis (2012) 0.79
Renal artery injury in child abuse. Child Nephrol Urol (1990) 0.79
Prognostic score for patients with localized renal cell carcinoma treated by nephrectomy. Isr Med Assoc J (2001) 0.78
A profile of the behavioral changes produced by facilitation of AMPA-type glutamate receptors. Psychopharmacology (Berl) (1997) 0.78
Second primary cancer in irradiated stage I testicular seminoma. Strahlenther Onkol (1993) 0.78
The role of nuclear morphometry for predicting disease outcome in patients with localized renal cell carcinoma. Cancer (1995) 0.78
Distilled water versus chemotherapeutic agents for transitional bladder carcinoma. Eur Urol (1986) 0.78
Urine cytology, tumour markers and bladder cancer. Br J Urol (1998) 0.78
Quantitative SPECT of 99mTc-DMSA uptake in kidneys of infants with unilateral ureteropelvic junction obstruction: assessment of structural and functional abnormalities. J Nucl Med (1999) 0.78
Low inguinal approach for correction of recurrent varicocele. Int Urol Nephrol (1998) 0.77
[Does percutaneous nephrolithotripsy (PCNL) affect renal function: assessment with quantitative spect of Tc 99M-DMSA (QDMSA) renal scintigraphy]. Harefuah (2005) 0.77
Treatment of verrucous epidermal nevus: experience with 71 cases. Dermatology (2013) 0.77
Obstructive jaundice caused by metastatic renal cell carcinoma. Eur Urol (1991) 0.77
Value of nuclear morphometry for differentiating localized from metastatic renal cell carcinoma. Eur Urol (1998) 0.77
Quantitation of renal uptake of technetium-99m DMSA using SPECT. J Nucl Med (1989) 0.76
Absence of peripheral-type benzodiazepine binding sites in renal carcinoma: a potential biochemical marker. Br J Urol (1989) 0.76